Abstract
Hip osteoarthritis is one of the most prevalent and most debilitating musculoskeletal pathologies worldwide. Its management is quite complex and relies on multiple therapeutic modalities that must be chosen and associated by the treating physician, in order to build offer his patient the best care. This optimal treatment for hip osteoarthritis should be tailored to each single patient, but, no matter how diverse it can be, it must invariably rely on 3 different types of modalities which have to be mixed and matched in the best possible way. These 3 pillars on which the doctor will build his therapeutic strategy are the non-pharmacologic, the pharmacologic and the surgical treatment modalities. However, given the great diversity of available options, one might need to be guided through this process, and to rely on solid evidence. That's why many scientific societies have issued guidelines for the management of hip osteoarthritis, aiming to make it easier and consensual. However, although these recommendations have several similarities and share many domains, they also show some discrepancies and point to conflictual questions that remain unsolved. Indeed, numerous points still need to be elucidated, and solid proofs to be gathered in order to solve these issues. Optimal and unanimously recognized new recommendations would be developed based on novel therapies and recent techniques.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.